HOOKIPA Pharma News

HOOKIPA Pharma Analyst Ratings

BenzingaJun 5 07:37 ET

Buy Rating Affirmed for Hookipa Pharma Amid Positive HB-200 Vaccine Trials and Robust Financial Position

TipRanksMay 24 14:55 ET

HOOKIPA Pharma Analyst Ratings

BenzingaMay 21 13:09 ET

Analysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)

TipRanksMay 21 07:01 ET

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)

TipRanksMay 14 04:40 ET

RBC Capital Initiates a Buy Rating on Hookipa Pharma (HOOK)

TipRanksMay 10 06:41 ET

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)

TipRanksMay 9 12:40 ET

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)

TipRanksApr 30 02:12 ET

HOOKIPA Pharma Analyst Ratings

BenzingaApr 26 06:52 ET

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)

TipRanksApr 26 06:20 ET

Buy Rating Affirmed for Hookipa Pharma Amidst Promising Pipeline and Strategic Advancements

TipRanksApr 24 14:45 ET

Optimistic Buy Rating for Hookipa Pharma Based on Promising HB-200 Trial Results and Strategic Trial Design

TipRanksMar 27 02:56 ET

Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Hookipa Pharma (HOOK) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksMar 25 06:30 ET

HOOKIPA Pharma Analyst Ratings

BenzingaMar 25 06:23 ET

Hookipa Pharma (HOOK) Receives a Buy From RBC Capital

TipRanksMar 24 21:48 ET

Buy Rating Affirmed for Hookipa Pharma on Emerging Oncology and Infectious Disease Pipelines

TipRanksMar 22 11:55 ET

Maintaining Buy Rating on Hookipa Pharma Amid Strategic Repositioning and Pipeline Promise

TipRanksFeb 1 00:07 ET

HOOKIPA Pharma Analyst Ratings

BenzingaJan 30 10:12 ET

Analysts' Top Healthcare Picks: Hookipa Pharma (HOOK), Catalent (CTLT)

TipRanksJan 30 07:12 ET

Strategic Focus on Promising HPV+ Cancer Candidate Underpins Buy Rating for Hookipa Pharma

TipRanksJan 29 11:35 ET